SBIR/STTR Research Award
Hurdle Health: Culturally Intentional Teletherapy to Address SUD and Co-Occurring Symptoms Amongst Black Men.
Award amount
$257,730Program and phase
SBIR · Phase IAward year
2022Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- HURDLE HEALTH INC
- Proposal award date
- 2022-08-15
- Contract end date
- 2023-01-31
- UEI
- U1FCTD9GJAR7
- Solicitation number
- DA22-001
- Topic code
- NIDA
Research abstract
Abstract (30 lines)
Black men experience a disproportionate amount of stress from high exposure to social, environmental, and economic
determinants of health. As a result, Black men face tremendous stress on a daily basis. In response, some Black men turn
to substance use to cope with the psychological pain and emotional distress of chronic unemployment, financial insecurity,
and racial discrimination. The purpose of this Phase I study is to test the feasibility of a teletherapy approach to treating
SUD in 20 Black/African American men over a three-month period. Treatment is delivered using a cloud-based mobile
health platform available via web desktop and “smart” mobile phones. The study emphasizes culturally informed
appropriate content designed to address the particular needs of Black men with SUD. The treatment approach is guided by
the Continuum of Broaching Behavior, a clinical framework that enhances therapists’ ability to engage race, ethnicity,
culture, and gender as integral parts of the treatment process. The aims are to: (1) Train and assess therapists in the use of
the Continuum of Broaching Behavior Model with Black men; (2) Adapt the Continuum of Broaching Behavior Model
for use in an online platform for Black men with SUD; (3) Implement a within-subjects, repeated-measures design to
assess the impact of the Continuum of Broaching Behavior Model on change in SUD and related symptoms of depression
and anxiety in 20 Black men over three months. This Phase I feasibility study positions Hurdle for a subsequent Phase II
between-subjects clinical trial. Together, Phases I and II of this research program will deliver a digitally-mediated
treatment approach that employs culturally informed teletherapy to promote positive coping strategies, increase client
satisfaction, and reduce premature termination in Black men with SUD.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)